National Health Investors, Inc. (NYSE:NHI - Free Report) - Wedbush reduced their FY2025 earnings per share estimates for National Health Investors in a note issued to investors on Wednesday, November 6th. Wedbush analyst R. Anderson now expects that the real estate investment trust will earn $4.58 per share for the year, down from their previous estimate of $4.64. The consensus estimate for National Health Investors' current full-year earnings is $4.48 per share.
A number of other research analysts also recently commented on NHI. StockNews.com downgraded National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Bank of America assumed coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a "buy" rating and a $92.00 price target for the company. Wells Fargo & Company downgraded shares of National Health Investors from an "overweight" rating to an "equal weight" rating and boosted their price objective for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Truist Financial upped their target price on National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a research note on Friday, August 30th. Four research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $73.29.
Get Our Latest Stock Report on NHI
National Health Investors Price Performance
National Health Investors stock traded up $1.90 during mid-day trading on Friday, reaching $81.54. 141,242 shares of the company were exchanged, compared to its average volume of 194,543. The company has a fifty day simple moving average of $80.37 and a 200-day simple moving average of $73.21. The firm has a market cap of $3.54 billion, a PE ratio of 27.09, a PEG ratio of 5.05 and a beta of 1.05. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. National Health Investors has a 12 month low of $50.12 and a 12 month high of $86.13.
National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The business had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. During the same quarter last year, the company posted $1.08 earnings per share. The company's revenue was up 1.7% on a year-over-year basis.
National Health Investors Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a yield of 4.42%. National Health Investors's dividend payout ratio is currently 122.45%.
Hedge Funds Weigh In On National Health Investors
Large investors have recently bought and sold shares of the company. Strategic Financial Concepts LLC bought a new stake in shares of National Health Investors in the second quarter worth $28,000. Covestor Ltd increased its stake in shares of National Health Investors by 2,700.0% in the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust's stock valued at $35,000 after buying an additional 405 shares during the period. International Assets Investment Management LLC bought a new position in shares of National Health Investors during the second quarter worth about $36,000. Blue Trust Inc. lifted its stake in shares of National Health Investors by 2,651.9% in the second quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust's stock worth $47,000 after acquiring an additional 716 shares during the period. Finally, Assetmark Inc. boosted its holdings in National Health Investors by 27.8% in the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust's stock valued at $54,000 after acquiring an additional 141 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors.
National Health Investors Company Profile
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
